SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 298,380 shares at $26.24 ($7.9M) on 2023-01-11, disclosed to the SEC on 2023-01-12.
Open-market sale of $7.9M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.41 | 70,575 | $1.9M | 23.7% |
| 2 | $26.41 | 70,575 | $1.9M | 23.7% |
| 3 | $25.92 | 900 | $23K | 0.3% |
| 4 | $26.24 | 78,165 | $2.1M | 26.1% |
| 5 | $26.24 | 78,165 | $2.1M | 26.1% |
| Total | $26.32 avg | 298,380 |
| $7.9M |
| 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |